Securities code: 002100 securities abbreviation: Tecon Biology Co.Ltd(002100)
Announcement No.: 2021-089 bond Code: 128030 bond abbreviation: Tiankang convertible bond
Non public offering of a shares
of
Summary of issuance report and listing announcement
Sponsor (lead underwriter)
December, 2001
hot tip
1、 Issue quantity and price
(i) Number of shares issued: 277449664
（2） Issue price: 7.45 yuan / share
（3） Nature of issued shares: RMB ordinary shares (A shares), tradable shares with restricted sales conditions
（4） Total funds raised: RMB 2066999996.80
（5） Net amount of raised funds: RMB 2043263919.66
2、 New stock listing arrangements
277449664 new shares will be listed on Shenzhen Stock Exchange on December 24, 2021. On the first day of listing of new shares, the company's share price does not ex right, and the stock trading is subject to rise and fall restrictions. 3、 Issuance and subscription and arrangement of restricted sale period
Serial number name of issuing object number of shares subscribed amount (yuan) proportion of subscribed amount in total share capital after issuance (shares)
1. Huaxia Fund Management Co., Ltd. 8859065999997.000 65%
2JPMorgan Chase Bank, National9,771,81272,799,999.400. 72%Association
3. China Southern Fund Management Co., Ltd. 1154362485999998.800 85%
4 Zhang Haiyan 805369159999997.950 59%
5 Penghua Fund Management Co., Ltd. 2214765116499999.951 64%
6 Harvest Fund Management Co., Ltd. 6477852348259996.354 78%
7 CAITONG Fund Management Co., Ltd. 31946308237999994.602 36%
8 China Galaxy Securities Co.Ltd(601881) 39,127,516291,499,994.202. 89%
9 Guotai Junan Securities Co.Ltd(601211) 11,382,55084,799,997.500. 84%
10 Nord Fund Management Co., Ltd. 16308724149993.801 20%
Serial number name of issuing object number of shares subscribed amount (yuan) proportion of subscribed amount in total share capital after issuance (shares)
11 Xinjiang Jintou Asset Management Co., Ltd. 805369159999997.950 59%
12 GF Fund Management Co., Ltd. 4547651433880029.303 36%
Total 2774496642066999996.8020 49%
According to the relevant provisions of the China Securities Regulatory Commission and Shenzhen Stock Exchange, the shares subscribed by the issuing object for this non-public offering shall not be transferred within 6 months from the date of completion of the offering. After the end of the restricted sale period, the transfer of the shares subscribed by the issuing object will be implemented in accordance with the company law of the people's Republic of China and other relevant laws and regulations, as well as the relevant provisions of the CSRC and Shenzhen Stock Exchange. 4、 Ownership structure
After the completion of this non-public offering, the equity distribution of the company meets the listing conditions specified in the stock listing rules of Shenzhen Stock Exchange.
catalogue
Special tips two
1、 Issue quantity and price two
2、 New stock listing arrangements two
3、 Issuance and subscription and arrangement of restricted sale period two
4、 Ownership structure 3 interpretation Section 1 basic information of this offering six
1、 Basic information of the issuer six
2、 Relevant procedures performed in this offering six
3、 Basic information of this offering eight
4、 Basic information of the issuing object twelve
5、 Relevant institutions of this issuance Section II listing of new shares twenty
1、 Approval for listing of new shares twenty
2、 Securities abbreviation, securities code and listing place of new shares twenty
3、 Listing time of new shares twenty
4、 Restrictions on the sale of new shares Section III comparison of relevant situations of the company before and after this issuance twenty-one
1、 Comparison of relevant situations before and after this issuance twenty-one
2、 The impact of this non-public offering on the company Section IV financial accounting information of the issuer and management discussion and Analysis twenty-five
1、 Description of the company's main financial data and preparation basis of financial indicators twenty-five
2、 Main financial data and financial indicators for the last three years twenty-five
3、 Management discussion and Analysis Section V concluding comments of the sponsor and the lead underwriter on the process of this non-public offering and the compliance of the issuing object Section VI concluding comments of the issuer's lawyer on the process of this non-public offering and the compliance of the issuing object Section VII recommendation opinions of recommendation institutions for listing 33 Section VIII documents for future reference thirty-four
interpretation
Unless otherwise specified, the following words in the summary of this issuance report and listing announcement have the following specific meanings:
Issuer / company / Tecon Biology Co.Ltd(002100) means Tecon Biology Co.Ltd(002100)
Controlling shareholder, state-owned assets company of Xinjiang production and Construction Corps, refers to the actual controller of State-owned Assets Management Co., Ltd. of Xinjiang production and Construction Corps
A shares / ordinary shares / shares refer to Tecon Biology Co.Ltd(002100) RMB ordinary shares listed on Shenzhen stock exchange with a par value of RMB 1 per share
This non-public offering / this offering refers to Tecon Biology Co.Ltd(002100) issuing A-Shares to no more than 35 specific objects to raise funds through non-public offering
This issuance report and listing refers to the announcement report and listing announcement on the issuance of Tecon Biology Co.Ltd(002100) non public Development Bank A shares
General meeting means Tecon Biology Co.Ltd(002100) general meeting of shareholders
Board of directors means the Tecon Biology Co.Ltd(002100) board of directors
CSRC / CSRC means China Securities Regulatory Commission
Registration company refers to Shenzhen Branch of China Securities Depository and Clearing Co., Ltd
Shenzhen stock exchange refers to Shenzhen Stock Exchange
Trading day refers to the trading day of Shenzhen Stock Exchange
The Company Law refers to the company law of the people's Republic of China, which is applicable and effective
Securities Law refers to the securities law of the people's Republic of China, which is applicable and effective
The measures for the administration of securities issuance refer to the measures for the administration of securities issuance by listed companies
The detailed rules for the implementation of non-public development banks refer to the detailed rules for the implementation of non-public development banks of listed companies
Articles of association means the Tecon Biology Co.Ltd(002100) articles of association
Sponsor / lead underwriter / CSC index China Securities Co.Ltd(601066) investment / China Securities Co.Ltd(601066) securities
Lawyer of the issuer refers to Beijing Zhonglun law firm
Capital verification institution / sigma refers to sigma Certified Public Accountants (special general partnership)
Yuan, ten thousand yuan and one hundred million yuan refer to RMB yuan, ten thousand yuan and one hundred million yuan
Issuer / company / Tecon Biology Co.Ltd(002100) means Tecon Biology Co.Ltd(002100)
Note 1: unless otherwise specified, all values in this issuance report and listing announcement summary shall retain 2 decimal places. In case of any discrepancy between the total number and the mantissa of the sum of the sub item values, it shall be caused by rounding. Note 2: unless otherwise specified, the financial data and financial indicators in the summary of this issuance report and listing announcement are consolidated statement data.
Section I basic information of this offering
1、 Basic information of the issuer
Company name Tecon Biology Co.Ltd(002100)
English Name: tecon biology Co.Ltd
Date of establishment: December 28, 2000
Listing date: December 26, 2006
Place of listing: Shenzhen Stock Exchange
Stock abbreviation Tecon Biology Co.Ltd(002100)
Stock Code: 002100 SZ
Legal representative: Yang Yan, Secretary of the board of directors: Guo Yunjiang
The total share capital is 10763342 yuan
Registered address: No. 528, South Changchun Road, Urumqi high tech Industrial Development Zone, Xinjiang
Office address: No. 528, South Changchun Road, Urumqi high tech Industrial Development Zone, Xinjiang
Production and sales of veterinary drugs; Production and sales of feed; Production of additive premixed feed; Production and sales of feed additives; Sales of Holstein cattle (the specific business scope and validity period of the above projects shall be subject to the license issued by relevant departments); import and export business scope of self-supporting and agency of various commodities and technologies (except for the commodities and technologies limited or prohibited by the state); technical consulting services related to the business scope; sales of agricultural and livestock products; edible Shenzhen Agricultural Products Group Co.Ltd(000061) Sales of; Equity investment, sales of agricultural and sideline products; Production and sales of fertilizers; Warehousing. (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments)
Note: the total share capital of the company changes with the conversion of "Tiankang convertible bonds". The total share capital of the company as of September 30, 2021 is listed here. According to the announcement on the conversion of convertible corporate bonds in the third quarter of 2021, as of September 30, 2021, the total share capital of the company was 1076334342 shares, and Tiankang convertible bonds were still listed for trading of RMB 88500000. 2、 Relevant procedures to be performed in this offering
(i) Internal decision-making procedures for this issuance
The issuer has performed the following internal decision-making procedures for this non-public offering:
1. On December 29, 2020, the issuer held the 13th meeting of the 7th board of directors and the 9th meeting of the 7th board of supervisors, deliberated and adopted the proposal on the company's non-public offering of shares in 2020 and other relevant proposals on the company's non-public offering of shares.
2. On January 18, 2021, the issuer received the reply on Tecon Biology Co.Ltd(002100) application for non-public offering of shares from the state owned assets supervision and Administration Commission of Xinjiang production and Construction Corps, and agreed to the issuer's non-public offering of shares.
3. On January 19, 2021, the issuer held the first extraordinary general meeting of shareholders in 2021, deliberated and approved the proposals related to the issuance adopted at the 13th meeting of the seventh board of directors, and agreed to authorize the board of directors of the company to handle the specific matters of the issuance.
4. On April 21, 2021, the issuer held the 15th meeting of the 7th board of directors and the 10th meeting of the 7th board of supervisors to consider and adopt relevant proposals on reducing the scale of raised funds by 33 million yuan. After adjustment, supplement working capital
